Lista de leitura, NOV/17

KNOWLES, Lori; LUTH, Westerly; BUBELA, Tania. Paving the road to personalized medicine: recommendations on regulatory, intellectual property and reimbursement challenges. Journal of Law and the Biosciences, 2017. MORGAN, Jake R. et al. Economic evaluation of HCV testing approaches in low and middle income countries. BMC Infectious Diseases, v. 17, n. 1, p. 697, 2017. VIEIRA, Mariana Gonçalves.... Continue Reading →

0

Lista de leitura, SET/17

RUDIANY, Novita Putri. Governing Global Health Care: A Case Study of India vis à vis Swirtzerland’s Novartis AG Regarding Patent of Gleevec. Jurnal Hubungan Internasional, v. 10, n. 1, p. 17-31, 2017. FIGUEIREDO, Tatiana Aragão; SCHRAMM, Joyce Mendes de Andrade; PEPE, Vera Lúcia Edais. The public production of medicines compared to the National Policy of Medicines... Continue Reading →

0

MARRS, Julian W. Forever Green? An Examination of Pharmaceutical Patent Extensions. 2017. BEER, Jeremy de. Open Innovation in Development: Integrating Theory and Practice Across Open Science, Open Education, and Open Data. openAIR, Jan/2016. ALSAIRI, Raniah. Access to Medicine in Developing Countries. American Journal of Medicine and Medical Sciences, v. 7, n. 6, p. 271-276, 2017. PIMENTEL, Vitor... Continue Reading →

0

MEAGHER, Kieran. Abuse of the Hatch-Waxman Act: Mylan's Ability to Monopolize Reflects Weaknesses. Brooklyn Journal of Corporate, Financial & Commercial Law, v. 11, n. 2, p. 589, 2017. Some of these practices include: reverse payments, citizen petitions, product hopping, and the misclassification of drugs. This Note argues that pharmaceutical companies have engaged in some of these... Continue Reading →

0

HENKEL, Alexis; ROSS, Joseph. The Effect of Acquisitions on Pharmaceutical Drug Prices. 2017. SILVA, Rafaela Cristina Pereira; CALIARI, Thiago. Indústria Farmacêutica no Brasil: Evolução Histórica, Capacitação Competitiva e Políticas Industriais. Revista Economia Ensaios, v. 31, n. 1, 2017. SANTOS SANTANA, Rafael; DE OLIVEIRA LUPATINI, Evandro; NAIR LEITE, Silvana. Registro e incorporação de tecnologias no SUS:... Continue Reading →

0

BRIGDEN, Grania et al. Tuberculosis and antimicrobial resistance–new models of research and development needed. Bulletin of the World Health Organization, v. 95, n. 5, p. 315, 2017. SCOPEL, Carolinne Thays. Modelo de análise das parcerias para o desenvolvimento produtivo de medicamentos na perspectiva da saúde pública. 2016. CHAVES, Gabriela Costa et al. Strategies for price... Continue Reading →

0

Powered by WordPress.com.

Up ↑